Antagonism by dibutyryl adenosine cyclic 3',5'-monophosphate and testololactone of concanavalin A capping by unknown
ANTAGONISM  BY  DIBUTYRYL  ADENOSINE  CYCLIC 
3',5'-MONOPHOSPHATE  AND 
TESTOLOLACTONE  OF  CONCANAVALIN  A  CAPPING 
BRIAN  STORRIE 
From the Department  of Biophysics and Genetics, Eleanor  Roosevelt Institute  for Cancer  Research, 
University  of Colorado Medical  Center,  Denver, Colorado 80220. Dr.  Storrie's present  address  is 
Memorial Sloan-Kettering Cancer Center,  New York 10021. 
ABSTRACT 
Exposure of CHO-K 1 cells in vitro to dibutyryl adenosine cyclic Y,5'-monophos- 
phate  (DBcAMP)  plus testololactone produces  a  rapid,  reversible antagonism  of 
ligand-induced  collection  of initially dispersed  concanavalin  A  (Con  A)  binding 
sites  into  a  caplike  mass.  Morphologically, as  Con  A  capping  occurs,  the  cells 
become less spread and then  round completely. With prolonged Con  A  exposure, 
cells cultured in either the absence or the presence of DBcAMP  plus testololactone 
cap and  round.  Capping  is blocked by cold treatment  and  respiratory inhibitors. 
Colcemid  at  concentrations  >1  aM  promotes  both  Con  A  capping  and  cell 
rounding.  Cytochalasin B  at similar concentrations inhibits both capping and cell 
rounding.  Treatment  of cells with Con  A  has  little effect  on  intracellular cAMP 
concentration. Possible mechanisms by which cAMP  may modulate the movement 
of Con  A  binding sites are discussed. 
Treatment of Chinese hamster ovary cells in vitro 
with 3', 5'-cyclic AMP (cAMP) analogues such as 
dibutyryl  cyclic  AMP  (DBcAMP)  or  8-bromo- 
cAMP, either alone or in synergistic combination 
with  testosterone,  theophylline, or  other  specific 
agents, converts cells from an epithelial-like to a 
fibroblast-like morphology (10-12,  20,  21). ~ This 
conversion  is  preceded  by  a  rapid,  reversible 
change  in  cell surface  properties (10,  28). ~ Cells 
cultured  on  solid  substrate  in  the  presefice  of 
DBcAMP plus testosterone become rapidly resist- 
ant to rounding by removal of divalent cations (28) 
or brief exposure to the lectin, concanavalin A (10, 
28).  Basically similar observations have been  re- 
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ported with other cell lines (15, 22, 34), suggesting 
that cAMP may be an important general agent in 
regulating  the  surface  properties  of mammalian 
cells. 
The  differential  response  of  Chinese  hamster 
ovary cells grown  in  the  absence  or presence  of 
DBcAMP plus testosterone to the rounding action 
of concanavalin  A  (Con  A)  is not  absolute (28). 
After a  time lag suggestive of an autocatalytic or 
cooperative process, cells treated  with  DBcAMP 
plus testosterone also round. The amount of Con 
A  bound  to  cells  cultured  in  the  absence  or 
presence of DBcAMP is equal (29). The process of 
Con A cell rounding is temperature dependent and 
blocked by inhibitors of cellular respiration such as 
azide, cyanide, or iodoacetate. One known cooper- 
ative  interaction  of  multivalent  lectins  or  anti- 
bodies with a  similar dependence on temperature 
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induced cap formation (9,  13, 30,  36). 
In  the  present work,  the distribution of Con  A 
bound to  Chinese hamster ovary cells cultured  in 
the absence or presence of DBcAMP plus testoloo 
lactone,  a  testosterone  derivative,  has  been  in- 
vestigated.  An  association  between  differential 
Con A  capping and cell rounding has been found. 
MATERIALS  AND  METHODS 
The Chinese hamster ovary cell clone CHO-K1  (16) was 
used in all experiments. Cells were routinely cultured on 
solid  substrate  as  described  previously  (28).  Unless 
otherwise  indicated,  cells  were  normally  exposed  to 
DBcAMP  plus testololactone at a  concentration of 0.3 
mM  and 33 ~tM  respectively, for  16-20 h after plating. 
Cells were treated with Con  A, and rounded cells were 
scored as described (28). 
For  assay  of the  distribution  of fluorescent Con  A 
bound to cells,  1 ￿  10  ~ cells were plated on 22-mm square 
glass coverslips in the absence or presence of DBcAMP 
plus  testololactone  and  challenged  16-20  h  later  by 
addition of fluorescein isothiocyanate conjugated Con A 
(fl-Con A, Yeda  Research and Development Co.,  Ltd., 
Rehovoth, Israel) at a concentration of 40 gg/ml (unless 
otherwise indicated) to the preexisting serum-containing 
medium. Cells were incubated with fl-con A for 30 min at 
37~  in  a  humidified CO2  incubator (unless otherwise 
indicated).  Incubations were  terminated by rinsing the 
coverslips briefly three times in phosphate-buffered sa- 
line  (5)  containing  DBcAMP  plus  testololactone  as 
appropriate,  at room temperature,  followed by fixation 
for two  min in  10% Carnoy's fixative. Coverslips were 
mounted in Elvanol (E.  1.  du  Pont de Nemours &  Co. 
Inc.,  Wilmington,  Del.)  and  observed  with  a  Leitz 
Orthoplan  microscope  fitted  with  a  vertical  Ploem  il- 
luminator.  Between  100  and  120  cells  were  scored  to 
assay frequency of Con A capped or rounded cells.  The 
specificity of fl-Con A binding was tested by pretreating 
cultures with ot-methylmannopyranoside (26) at a  con- 
centration of 0.05  M.  Staining is  inhibited completely 
by o~-methylmannopyranoside at this concentration. 
In  experiments to  test  the  effect  of temperature on 
fl-Con A  capping, cultures were preincubated for 5 min 
with cooled medium (2~  minus or plus DBcAMP and 
testololactone and  with 20 mM  Hepes  buffer (pH  7.2) 
added to control medium pH outside the CO~ incubator. 
Cultures were then incubated with either 40 ~.g/ml or 100 
~.g/ml fl-con A (to compensate for the decreased Con A 
binding at 2~  [29]).  In inhibitor experiments, cultures 
were pretreated for 30 min with agent(s) before Con A 
addition. In some experiments, cells were fixed in freshly 
prepared  1% formaldehyde in phosphate-buffered saline 
for 10 min at 37~  (32) before exposure to fI-Con A. 
Electron microscope visualization of Con A bound to 
glutaraldehyde-prefixed  cells  was  carried  out  by  slight 
modifications of the peroxidase-diaminobenzidine proce- 
dure (17).  In brief, 8  ￿  105 cells were plated per 60-mm 
plastic petri dish (Lux Scientific Corporation, Thousand 
Oak,  Calif.)  in  the  absence  or  presence  of  DBcAMP 
plus  testololactone  as  appropriate,  then  rinsed,  and 
exposed  to  40  ~g/ml  Con  A  for  30  min  at  37~  in 
serum-containing  medium.  After  a  second  fixation, 
peroxidase  was  added,  and  the  culture  was  rinsed, 
and  treated  with  diaminobenzidine.  Cells  were  post- 
fixed  with  1%  osmium  tetroxide  in  0.1  M  collidine 
buffer  for  1  h  at  22~  dehydrated,  and  detached 
from  the  petri  dish  in  sheets  with  amyl  acetate  (23). 
Pellets  were  embedded  in  Epon  812  (Shell  Chemical 
Co., New York, N. Y.) and gold-to-silver sections were 
cut with a diamond knife. Sections were examined with a 
Philips 200  electron  microscope  set  at  60 kV.  Peroxi- 
dase-diaminobenzidine  staining  was  completely  pre- 
vented by the addition of 0.05 M a-methylmannopyrano- 
side during Con A and peroxidase binding. 
lntracellular cAMP levels were measured by the pro- 
tein kinase binding assay as described previously  1. Paral- 
lel cultures were fixed  and stained for assay of rounded 
cells as described previously (28).  Cell number was as- 
sayed  with  a  Coulter counter.  For total cell counts of 
cultures incubated with Con  A  for several h, cells were 
detached by 0.25% trypsin after exposing cultures to 0.05 
M  a-methylmannopyranoside  for  15  min  at  37~  in 
serum-containing media. 
RESULTS 
Effect of DBcA MP plus  Testololactone  on 
Con A  Distribution 
When CHO-KI  cells grown on solid substrate in 
the absence or presence of 0.3 mM  DBcAMP plus 
33/~M testololactone are fixed and then incubated 
with 40 #g/ml Con  A  at 37~  the distribution of 
fl-Con A  bound to cells under either culture regime 
is  identical.  Prefixed  cells  of either epithelial-like 
or fibroblast-like morphology treated  with  fl-Con 
A  stain  diffusely  and,  essentially,  uniformly  over 
the entire cell under both culture conditions (Fig.  1 
A,B).  Cells  prefixed  with  glutaraldehyde  and 
stained  by  the  peroxidase-diaminobenzidine 
method  for bound Con  A  show a  correspondingly 
uniform  distribution  of  Con  A,  as  indicated  by 
the  electron-dense  deposit,  about  the  cell  pe- 
riphery (Fig.  1 C,D). 
If,  however,  cells  cultured  in  basal  medium  or 
medium  supplemented  with  DBcAMP  plus  tes- 
tololactone  are  incubated  with  Con  A  before 
fixation, the distribution of Con A  bound to either 
cell  population  during  brief Con  A  exposures  is 
markedly  dissimilar  (Fig.  2).  After  a  30-min 
exposure  to fl-con A, a  high proportion of cells in 
BRIAN STORRIE  Antagonism of Concanavalin A Capping  393 FIGURE  1  Distribution  of  Con  A  bound  to  formaldehyde-prefixed  (A,B)  or  glutaraldehyde-prefixed 
(C,D) cells cultured in the absence (A,C) or presence (B,D) of DBcAMP plus testololactone. (A,B)  x  675; 
(C,D).  ￿  ~60,000. 
394  THE JOURNAL OF CELL BIOLOGY  -  VOLUME 66,  1975 FIGURE 2  Distribution of fl-Con A bound to cells exposed  to 40 #g/ml fl-Con A for 30 min (A,B) or 4 h 
(C,D)  before  fixation.  Cells were  cultured  in  the  absence  (A,C)  or  presence  (B,D)  of  DBcAMP  plus 
testololactone for  18 h before fl-Con A addition. (A,B) ￿  500:  (C,D) x  675. 
basal  medium  is stained  only over a  small portion 
of the cell in a cap-like mass located perinuclearly 
on  the top  side of the cell (Fig. 2  A).  In contrast, 
cells  in  DBcAMP  plus  testololactone-containing 
medium  treated  identically  with  fl-Con  A  for  30 
min are stained  in a somewhat patch-like distribu- 
tion over the entire cell (Fig. 2  B). However, if the 
duration  of Con A  exposure is prolonged,  cells in 
the presence of DBcAMP plus testololactone also 
cap.  Thus,  after  4  h,  a  large  fraction  of  either 
population  exposed  to fl-Con A  is capped,  and the 
cells in  basal  medium  are  largely  rounded  (Fig.  2 
C,D). 
Quantitatively  > 50%  of the  cells  in  basal  me- 
dium  cap  during  a  30-min  exposure  to  fl-con  A 
(Fig.  3).  Only  3%  of the  cells  in  the  presence  of 
DBcAMP plus testololactone cap during a 30-min 
exposure,  but  by 2 h  of exposure  >  50% of cells in 
media  supplemented  with  DBcAMP  plus  tes- 
tololactone  are  also  capped.  Kinetically,  Con  A 
capping  precedes  cell rounding  by  several  min  in 
the case of cells in basal medium,  and by hours  in 
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cells  (Fig.  3).  Cells  appear  to  become  first  less 
spread  and  then  round  as the Con A  caps. 
Effect of Synergistic Agents and Respiratory 
Inhibitors  on Con A  Distribution 
Cyclic AMP antagonism of Con A cell rounding 
demonstrates synergism with testololactone, a  ste- 
roid  hormone  analogue,  or  theophylline,  a  phos- 
phodiesterase  inhibitor,  occurs  rapidly,  and  is 
readily  reversible (28).  Antagonism  by  DBcAMP 
plus  testoiolactone  of  Con  A  capping,  if it  is  a 
cAMP effect, should behave similarly, and, in fact, 
it does.  Complete to  nearly complete antagonism 
of Con A  capping can be produced synergistically 
by 0.3  mM DBcAMP plus testololactone or theo- 
phylline or by DBcAMP alone at a concentration 
of  1.0  mM  (Table  I).  Addition  or  deletion  of 
DBcAMP plus testololactone elicits an essentially 
complete alteration  in the Con A-capping proper- 
ties  of CHO-KI  cells  in  a  1 h  period  (Table  II). 
This  is  a  much  more  rapid  event  than  the gross 
conversion of C HO-K 1 cells from epithelial-like to 
fibroblast-like  morphology  after drug  addition  or 
the  converse  change  after  drug  removal  which 
requires 8 or 4  h,  respectively (28). 
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FIGURE 3  Kinetics of Con A capping and cell rounding 
in the absence or presence  of DBcAMP plus testoiolac- 
tone.  Cells were cultured in the absence  or presence of 
drug  for  18  h  before fI-Con A  addition. O------O, fre- 
quency  of  cells  capped  in  absence  of  DBcAMP  plus 
testololactone; O  O,  frequency of ceils  rounded  in 
absence  of DBcAMP plus testololactone; ￿9  ￿9  fre- 
quency  of cells  capped  in  presence  of DBcAMP  plus 
testololactone; and  A  A, frequency of cells rounded 
in presence  of DBcAMP plus testololactone. 
TABLE  I 
Synergistic Antagonism by Testololactone or 
Theophylline and DBcAMP of Con ,4 Capping 
Frequency of cells capped 
by 30-rain challenge with 
Agents added  40 #g/ml fl-Con A 
% 
None  61 
Testololactone (33 #M)  60 
Theophylline (0.3 mM)  56 
DBcAMP (0.3 mM)  53 
(l.0mM)  9 
DBcAMP  (0.3: mM)  plus  tes-  7 
tololactone (33 ,aM) 
DBcAMP (0.3  mM) plus theo-  20 
phylline  (0.3 raM) 
Cells  were  plated  in  basal  medium  in  the  absence  or 
presence of agents as indicated.  17 h postplating fI-Con A 
was added  to the preexisting  medium. 
TABLE il 
Rapidity and Reversibility of DBcA  MP plus 
Testololactone Antagonism of Con A Capping 
Treatment 
Frequency of cells 
capped by 30-min 
challenge with 40 
#g/ml fl-Con A 
% 
Continuous exposure 
No addition  54 
+  DBcAMP  +  testololac-  5 
tone 
1 h post addition of DBcAMP  9 
plus testololactone 
1 h post deletion of DBcAMP  46 
plus testololactone 
Cells  were  plated  on  cover  slips  in  the  absence  or 
presence of DBcAMP plus testololactone and transferred 
17.5  h  postplating  to  fresh  warm  medium  containing 
DBcAMP plus testololactone as appropriate. 
Con A  cell rounding is blocked by low tempera- 
ture  and  is  sensitive  to  inhibitors  of  cellular 
respiration. Con A capping similarly is blocked by 
low  temperature  and  is  retarded  by  azide  and 
iodoacetate,  inhibitors  of  cellular  respiration 
(Table  III). 
Effect  of Colcemid  and  Cytochalasin  B  on 
Con A  Cell Rounding  and Capping 
Colcemid,  an  agent  known  to  disrupt  micro- 
tubules  (33),  and  cytochalasin  B,  a  presumed 
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Effect of Cold Treatment and lnhibitors  of 
Respiration on Con A  Capping 
Frequency of cells 
capped by 30-min 
challenge with 40 pg/ml 
fl-Con A 
Treatment  -DBcAMP  +DBcAMP 
%  % 
No addition  67  3 
2~  *  O  0 
+  10  mM  sodium  azide,  29  0 
10 pM iodoacetate 
Cells  were  plated  on  cover  slips  in  the  absence  or 
presence of DBcAMP plus testololactone. 19 h postplat- 
ing cells were pretreated with inhibitor and then exposed 
to fl-Con A in the presence of inhibitor. 
*Cells  were  incubated  with  100  pg/ml  fl-Con  A  to 
compensate for the decreased Con A binding that occurs 
at 2~  No capping is observed with 40 #g/ml fl-Con A 
at 2~ 
inhibitor  of  microfilament  function  (25,27),  at 
concentrations  _<  !  #M  completely  block  the 
cAMP-induced conversion of CHO-KI  cells from 
an  epithelial-like  to  fibroblast-like  morphology 
(11).  At  these  concentrations,  the  drugs  have 
marginal-to-negligible effects on Con A cell round- 
ing (28,  Fig.  4) and little, if any, effect on Con A 
capping (Table  IV). 
However,  at  concentrations  >1  #M,  colcemid 
promotes Con A  cell rounding (Fig. 4) and Con A 
capping (Figs.  5 and 6, Table IV). With increasing 
concentrations  of  Colcemid,  cells  grown  in  the 
presence of DBcAMP  plus testololactone become 
increasingly sensitive to the cell rounding action of 
Con  A.  At  a  Colcemid  concentration  of 20  pM, 
these ceils  become  as  sensitive to  Con  A  as cells 
grown in basal medium. Treatment of cells grown 
in basal medium  with concentrations of Colcemid 
to  20  pM  causes  a  small  increase  in  Con  A  cell 
rounding  which  is  only  slightly  greater  than  the 
accumulation  of rounded  mitotic cells (~7%) ob- 
served  in  parallel  non-Con  A-treated  cultures. 
Colcemid  treatment  causes  cells  cultured  in  the 
presence  of  DBcAMP  plus  testololactone  to  as- 
sume a  more epithelial-like morphology. Colcemid 
(10 #M) causes a definite increase in the frequency 
of cells in basal medium which cap during a 30-rain 
exposure to fl-Con A  and a  15-fold  increase in the 
frequency of cells in DBcAMP plus testololactone 
medium  that form caps. 
TABLE  IV 
Effect of Colcemid and Cytochalasin B on Con A 
Capping 
Frequency of cells 
capped by 30-min 
challenge with 40 #g/ml 
fl-Con A 
Treatment  -DBcAMP  +DBcAMP 
%  % 
No addition  65  2 
Colcemid 
!  #M  71  10 
10#M  77  33 
Cytochalasin B 
0.84#M  66  2 
10.00 pM  2  1 
Cells  were  plated  on  cover  slips  in  the  absence  or 
presence of DBcAMP plus testololactone. 17 h postplat- 
ing cells were pretreated with inhibitor and then exposed 
to fl-Con A in the presence of inhibitor. 
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FIGURE  4  Effect  of Colcemid  and  cytochalasin  B  on 
Con A cell rounding. Cells were grown in the absence or 
presence  of  DBcAMP  plus  testololactone,  pretreated 
with  Colcemid  or  cytochalasin  B,  and  exposed  to  40 
pg/ml  Con  A  for  2  h  in  the  presence  of  inhibitor. 
O  O,  dose-effect  relationship  for  cells  cultured  in 
basal  medium  and  treated  with  Colcemid;  []  •, 
dose-effect  relationship for  cells cultured  in  basal me- 
dium  and  treated  with cytochalasin B; 11----O,  dose- 
effect  relationship for  cells cultured  in  DBcAMP  plus 
testololactone-containing  medium  and  treated  with 
Colcemid; and S~---1,  dose-effect relationship for cells 
cultured in DBcAMP plus testololactone-containing me- 
dium and treated with cytochalasin B. 
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pletely Con  A  cell rounding  of cells in  either the 
absence  or  the  presence  of  DBcAMP  plus  tes- 
tololactone  (Fig.  4).  Cytochalasin  B  (10  #M) 
prevents  the formation  of a  centrally located Con 
A cap in the case of ceUs in either the absence or the 
presence  of DBcAMP  plus  testololactone  (Table 
IV).  Con  A  collection does  occur,  though,  at this 
concentration  of cytochalasin  B.  At  the end  of a 
30-min exposure to fl-Con A  in the presence of cy- 
tochalasin  B,  fl-Con A  is found  scattered  in large 
clusters or minicaps in the case of cells cultured in 
either  basal  medium  or  in  medium  containing 
DBcAMP plus testololactone.  (Figs.  5  and  6). 
FIGURE 5  Effect of Coicemid and cytochalasin B on the distribution of fl-Con A bound to cells grown in 
basal medium. Cells were cultured in basal medium for 18 h, pretreated with Colcemid, cytochalasin B, or 
Colcemid and cytochalasin B together, and exposed  to fl-Con A for 30 rain in the presence  of inhibitor. In 
(A) no addition; (B)  10 ~zM Colcemid; (C)  10 uM cytochalasin B; and (D)  10 #M Colcemid plus  I0 uM 
cytochalasin B.  ￿  675. 
398  THE JOURNAL OF CELL BIOLOGY  .  VOLUME 66,  1975 FIGURE 6  Effect of Colcemid and cytochalasin B on the distribution of fl-Con A bound to cells grown in 
the  presence  of DBcAMP  plus  testololactone.  Cells were  cultured  in  the  presence  of DBcAMP  plus 
testololactone  for  18  h,  pretreated  with  Colcemid,  cytochalasin  B,  or  Colcemid  and  cytochalasin  B 
together, and exposed  to fl-Con A for 30 min in the presence of inhibitor. In (A) no addition; (13) 10 uM 
Colcemid; (C)  10 uM cytochalasin B, and (D)  10 ~tM Colcemid plus  10 ~M cytochalasin B.  x  675. 
Treatment of cells with  10 #M Colcemid and  10 
#M  cytochalasin  B together  blocks cell rounding, 
and  the  formation  of a  central  Con  A  cap,  and 
results  in  minicaps  that  tend  to  be  located  about 
the cell periphery (Figs.  5  D  and 6  D). Synergistic 
interaction  between  Colcemid and  cytochalasin  B 
in  inhibiting Con  A  capping  was  not  observed.  If 
cells which had been exposed  for 30 min to fl-Con 
A  are  post  incubated  in  Con  A-free  medium 
containing  cytochalasin  B  (10  uM)  for  30  min, 
further  cap formation  is prevented, and a  reversal 
of  50%  of  the  caps  present  at  the  start  of  the 
post-incubation  occurs  (Table  V)  in  agreement 
with  recent  observations of de  Petris  (4). 
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Effect of Colcemid and Cytochalasin B on 
Preexisting Con A  Caps 
Frequency of 
Treatment  cells capped 
% 
No postincubation  64 
30-min fl-Con A-free 
medium postincubation 
No addition  90 
+ 10 ~M colcemid  85 
+ I  0 #M cytochalasin B  32 
Cells were plated on cover slips in basal medium, exposed 
for 30 rain  to fl-Con A, and then either fixed immediately 
or transferred to fI-Con A-free medium. 
Effect of Con A  on  Intracellular cAMP 
Levels 
Recent observations by Willingham et al.  (34) 
indicate that  a  drop  in  intracellular cAMP  lev- 
els  results  in  the  spontaneous  rounding  of  a 
temperature-sensitive  variant  of  mouse  3T3 
cells.  Con  A  rounding could  be  due  to  a  Con 
A-induced depression of intracellular cAMP lev- 
els.  Such a depression does not occur (Fig. 7).  In 
fact,  under conditions in which  Con A  rounds an 
appreciable fraction of the cell population, there is 
a slight elevation in intraceUular cAMP levels. In a 
cell  population  94%  rounded,  cAMP  levels  are 
raised by approximately 25% (Fig. 7 b). 
DISCUSSION 
The  difference  in  the  rate  of Con  A  capping 
between CHO-K1 cells grown in the absence and 
those  grown  in  the  presence  of  DBcAMP  plus 
synergistic concentrations of testololactone corre- 
lates with the previously reported differential Con 
A-rounding response  of such  cells (10,28).  Mor- 
phologically, the centripetal collection of initially 
disperse Con A-binding sites into a cap-like mass 
is  accompanied  by  a  decrease  in  cell  spreading 
followed by a  complete rounding of the cell.  The 
possibility that Con A capping is a consequence of 
cell rounding is eliminated by the fact that kineti- 
cally, capping precedes rounding. 
That Con A  capping may be a  causal event in 
Con  A  cell  rounding is  suggested  by the  similar 
effect  of cAMP and inhibitors on both processes. 
The  addition  of  cAMP  analogues  rapidly  and 
reversibly antagonizes both  Con  A  capping and 
cell rounding. Both appear to be the result of active 
metabolic processes.  Capping  and  cell  rounding 
are both  blocked by low temperature and inhibi- 
tors  of cellular respiration and  are  similarly af- 
fected  by inhibitors of microtubule or microfila- 
ment  function.  That  the  action  of  Con  A  in 
rounding cells could be modulated by a depression 
in intracellular cAMP levels can likely be excluded 
by the fact that cAMP levels are actually slightly 
elevated. The possibility that Con A in binding to 
the cells causes a transient depression in intracellu- 
lar  cAMP  levels  cannot,  though,  be  absolutely 
excluded.  While this manuscript was in prepara- 
tion, other authors (32) reported that cell rounding 
is  accelerated by Con A  capping and that  under 
conditions where  cell  bound Con A  remains dis- 
persely distributed, cells do not round. 
Possible mechanism(s) by which Con A capping 
and  cell  rounding may  be  related  can  presently 
only be speculative. That simple binding of Con A 
to  cells  followed  by  redistribution  of  Con  A 
binding sites is not sufficient to cause Con A cell 
rounding is indicated by the inhibition by  10 #M 
cytochalasin B of Con A cell rounding even though 
extensive redistribution of Con A binding sites into 
scattered  minicaps does occur under these condi- 
tions.  The  oriented collection of Con  A  binding 
sites into a single centrally located cap may cause 
the disruption or organized reorientation of intra- 
cellular components. Transmembrane linkage of 
lectin-binding  sites to intracellular components has 
recently  been  reported  to  occur  in  erythrocytes 
(14,19).  Other  more  indirect  effects  of  Con  A 
capping on the  small molecule or ionic composi- 
tion of the cell may be important. More likely, the 
formation of a centrally located Con A cap may be 
related  to  Con  A  cell  rounding  by  triggering 
internalization of the plasma membrane and con- 
sequent  rounding  of  the  cell  to  minimize  cell 
surface  area.  A  time  lag  between  capping  and 
membrane internalization, particularly in the case 
of ceils cultured in the presence of DBcAMP plus 
testololactone,  could  explain  the  observed  delay 
between Con A capping and cell rounding. Prelim- 
inary  electron  microscope  observations  indicate 
that  internalization of Con A  caps does occur in 
CHO-KI  populations. This hypothesis is consist- 
ent with recently reported observations of Edelson 
and Cohn (7,8)  that  Con  A treatment of macro- 
phages  promotes  pinocytosis  and  results  in  the 
formation  of  metabolically stable  Con  A  pino- 
somes. This hypothesis is currently being investi- 
gated. 
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The mechanism by which cAMP may modulate 
movement or collection of Con A-binding sites in 
the cell membrane is obscure. No matter what the 
actual  structure  modulated by cAMP  in antago- 
nizing Con  A  capping, the  event could  result in 
either the anchoring of the lectin receptor in place 
or the disengagement of the Con A receptor from 
the capping process.  Since CHO-KI cells cultured 
in  the  absence  or  presence  of  DBcAMP  plus 
testololactone  are  nonmotile,  the  effect  is  not 
related to translational cell motility. The effect  of 
Colcemid in promoting Con A  cell rounding and 
capping,  particularly  of  cells  treated  with 
DBcAMP  plus  testololactone,  is  consistent with 
the  proposal  by  other  authors  (2,6,31,37)  that  a 
membrane-associated, drug-sensitive, microtubu- 
lar  network  may  regulate  cell  surface  receptor 
mobility. Cytochalasin B, a presumed inhibitor of 
microfilament function (25,27),  has been reported 
by Ukena et al. (32),  in the case of SV-40-trans- 
formed 3T3 cells,  to inhibit Con A capping with a 
consequent random distribution over the entire cell 
surface  of large  Con  A  patches  being observed. 
However, the interpretation of these drug effects  is 
not clear. Observations by Sheetz and Singer (24) 
indicate that direct intercalation in the lipid bilayer 
of the membrane may be the primary explanation 
of  many  drug  effects  rather  than  disruption  of 
intracellular structures. 
Cyclic  AMP  modulation  of  lectin  receptor 
movement may be related to the differences in cell 
surface and growth properties between normal and 
transformed  cells.  In  general,  transformed  cells 
have lower cAMP levels than normal cells (1) and 
are  more  agglutinable by  lectins (3).  If,  as  sug- 
gested  by  Nicolson  (18),  cell  agglutinability by 
lectin reflects receptor mobility, then agglutinabil- 
ity may be a reflection of cAMP levels. 
Recently reported  Con-A-resistant variants of 
CHO cells that bind normal amounts of lectin (35) 
could be  variants in Con  A  capping.  If so,  such 
cells,  together with the techniques of somatic cell 
genetics,  could  provide  a  genetic  approach  to 
analysis of receptor movement. 
Cyclic AMP antagonism of Con A capping and 
cell  rounding  and  the  attendant  conversion  of 
CHO-KI  cells from  an epithelial-like to  a  fibro- 
blast-like  morphology  appear  to  be  completely 
dissociable  processes.  DBcAMP  plus  testololac- 
tone addition produces a complete antagonism of 
Con A capping in time intervals during which  no 
appreciable  alteration  in  cell  morphology  has 
occurred. A similar difference in kinetics between 
the  onset  of  cAMP  antagonism  of  Con  A  cell 
rounding and the conversion of the cell population 
to a fibroblast-like morphology has been reported 
previously (28).  Furthermore, Colcemid and cyto- 
chalasin  B  at  concentrations of  <  1 #,M  under 
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elongation to a fibroblast form (I 1) do not noticea- 
bly affect capping or cell rounding. 
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